Analysis Akzo Nobel India Limited (AKZOINDIA)
5/24/2024
Analysis of Akzo Nobel India Limited (AKZOINDIA)
Akzo Nobel India Limited has shown a relatively stable performance over the past few days. The stock price has been fluctuating within a narrow range, with the RSI indicator hovering around 55-60, indicating a balanced market sentiment.The MACD indicator has been positive, showing an upward trend in the stock price. The MACD histogram has also been increasing, indicating a strengthening bullish momentum.
The Moving Average (MA) indicator, both Simple Moving Average (SMA) and Exponential Moving Average (EMA), have been trending upwards, suggesting a positive outlook for the stock in the short term.
Overall, based on the technical indicators, Akzo Nobel India Limited seems to be in a bullish phase, with potential for further price appreciation in the near future. However, investors should continue to monitor the stock's performance closely for any changes in the trend.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a specific company. Here is a summary of the key information:1. Financials:
- Cash Flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance Sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit Margin: 26.306%
- Fiscal Year Ends: September 30, 2023
- Income Statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.44, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating Margin: 30.743%
- Return on Assets TTM: 22.073999%
- Return on Equity TTM: 147.25%
2. Stock Statistics:
- Short Ratio: 1.66
- Float Shares: 15,308,320,742
- Shares Short: 94,308,265
- Average 10-Day Volume: 52,903,608
- Average 90-Day Volume: 62,823,269
- Shares Outstanding: 15,334,099,968
- Percent Held by Insiders: 5.22%
- Percent Held by Institutions: 57.555%
- Short Percent of Shares Outstanding: 0.62%
3. Valuation Metrics:
- PEG Ratio: 26.213001
- Forward PE: 26.213001
- Trailing PE: 29.428572
- Enterprise Value: $2,948,462,018,560
- Price to Book MRQ: 39.181313
- Price to Sales TTM: 7.6151557
- Enterprise to EBITDA: 22.745
- Enterprise to Revenue: 7.726
- Market Capitalization: $2,906,118,684,672
4. Stock Price Summary:
- Beta: 1.264
- 50-Day Moving Average: $173.6936
- 200-Day Moving Average: $180.7906
- 52-Week Low: $164.08
- 52-Week High: $199.62
- 52-Week Change: 8.253%
5. Dividends and Splits:
- Payout Ratio: 14.93%
- Dividend Date: May 16, 2024
- Last Split Date: August 31, 2020
- Ex-Dividend Date: May 10, 2024
- Last Split Factor: 4-for-1 split
- Forward Annual Dividend Rate: $1
- 5-Year Average Dividend Yield: 0.73%
- Forward Annual Dividend Yield: 0.5266761603816345%
- Trailing Annual Dividend Rate: $0.97
- Trailing Annual Dividend Yield: 0.5108758755701854%
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company experienced a steady increase in revenue from 2020 to 2022, reaching its peak in 2022. However, there was a slight decrease in revenue in 2023 compared to 2022. This trend indicates a period of growth followed by a slight decline in revenue for the company.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and accounts receivable, with cash and cash equivalents showing fluctuations over the years.
3. Non-current assets consist of investments, machinery, furniture, and equipment, which have been increasing steadily.
4. Total liabilities have also been increasing, with a significant rise from 2022 to 2023.
5. Current liabilities include short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities comprise long-term debt and other non-current liabilities.
7. Shareholders' equity has shown variations, with retained earnings being a significant component.
8. The company seems to be investing more in non-current assets over the years, possibly for future growth and expansion.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities have a significant impact on the company's cash position, with large amounts being used for common stock repurchase and debt issuance.
4. Investing activities show a mix of acquisitions, capital expenditures, and investments, with varying levels of cash flow impact each year.
5. Interest paid and income tax paid have also varied over the years, affecting the company's overall cash flow position.
6. The end cash position has fluctuated, but the company has maintained a healthy cash reserve throughout the years.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates a slight increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This forecast suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a positive outlook for the company, with expected growth in both quarterly and annual sales over the coming quarters and years.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the past performance. However, the company is still projected to experience healthy growth over the next few years according to analyst consensus.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of AKZOINDIA
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
